KROS Keros Therapeutics | $55.92
+3.9% | 11/22/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | N/A | View details for Cantor Fitzgerald rating of Keros Therapeutics (NASDAQ:KROS) on 11/22/2024 |
CDXS Codexis | $4.61
+6.5% | 11/22/2024 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $11.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of Codexis (NASDAQ:CDXS) on 11/22/2024 |
RBRK Rubrik | $51.19
+4.2% | 11/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 11/20/2024 |
CRWD CrowdStrike | $372.26
+4.1% | 11/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 11/20/2024 |
CRWD CrowdStrike | $372.26
+4.1% | 11/21/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $350.00 -> $370.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 11/21/2024 |
WIX Wix.com | $217.20
-0.9% | 11/21/2024 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $200.00 -> $240.00 | N/A | View details for Cantor Fitzgerald rating of Wix.com (NASDAQ:WIX) on 11/21/2024 |
|
NVDA NVIDIA | $141.95
-3.2% | 11/21/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $175.00 -> $175.00 | N/A | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 11/21/2024 |
KURA Kura Oncology | $10.80
+7.4% | 11/21/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Kura Oncology (NASDAQ:KURA) on 11/21/2024 |
PANW Palo Alto Networks | $383.36
-3.6% | 11/21/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $445.00 -> $445.00 | N/A | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 11/21/2024 |
ACRS Aclaris Therapeutics | $3.80
-12.0% | 11/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst L. Chen | Neutral -> Overweight | | N/A | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/20/2024 |
MDGL Madrigal Pharmaceuticals | $347.45
+5.5% | 11/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Neutral | | N/A | View details for Cantor Fitzgerald rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 11/20/2024 |
QCOM QUALCOMM | $156.79
+0.9% | 11/20/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $160.00 -> $160.00 | N/A | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 11/20/2024 |
ZS Zscaler | $210.96
+1.8% | 11/18/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Hold | | N/A | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 11/18/2024 |
HIVE HIVE Digital Technologies | $4.09
+2.3% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $9.00 -> $9.00 | N/A | View details for Cantor Fitzgerald rating of HIVE Digital Technologies (NASDAQ:HIVE) on 11/19/2024 |
RCKT Rocket Pharmaceuticals | $14.11
+10.3% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 -> $65.00 | N/A | View details for Cantor Fitzgerald rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 11/19/2024 |
AFMD Affimed | $2.62
-0.8% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Affimed (NASDAQ:AFMD) on 11/19/2024 |
PCT PureCycle Technologies | $11.93
+2.1% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $14.00 | N/A | View details for Cantor Fitzgerald rating of PureCycle Technologies (NASDAQ:PCT) on 11/19/2024 |
INCY Incyte | $71.72
+1.9% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral | | N/A | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 11/19/2024 |
FTNT Fortinet | $92.77
-1.3% | 11/19/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $88.00 -> $95.00 | N/A | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 11/19/2024 |
SYM Symbotic | $38.79
+6.9% | 11/19/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 -> $60.00 | N/A | View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 11/19/2024 |
SEPN Septerna | $22.00
+1.0% | 11/19/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | $50.00 | N/A | View details for Cantor Fitzgerald rating of Septerna (NASDAQ:SEPN) on 11/19/2024 |
SSTI SoundThinking | $12.36
+5.3% | 11/14/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 11/14/2024 |
CDXS Codexis | $4.61
+6.5% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $11.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of Codexis (NASDAQ:CDXS) on 11/15/2024 |
AMAT Applied Materials | $174.88
-0.5% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $250.00 -> $250.00 | N/A | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 11/15/2024 |
ASND Ascendis Pharma A/S | $129.81
+5.8% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $170.00 -> $170.00 | N/A | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/15/2024 |
ELUT Elutia | $4.12
-6.4% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | N/A | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 11/15/2024 |
LUCD Lucid Diagnostics | $1.00
| 11/15/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 -> $2.00 | N/A | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 11/15/2024 |
ANNX Annexon | $5.14
-0.6% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 11/15/2024 |
SPRO Spero Therapeutics | $1.16
-2.5% | 11/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Spero Therapeutics (NASDAQ:SPRO) on 11/15/2024 |
LUNR Intuitive Machines | $15.12
+8.0% | 11/15/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $15.00 | N/A | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 11/15/2024 |
OMER Omeros | $10.91
+41.1% | 11/14/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral | | N/A | View details for Cantor Fitzgerald rating of Omeros (NASDAQ:OMER) on 11/14/2024 |
CSLR Complete Solaria | $1.94
| 11/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $6.00 | N/A | View details for Cantor Fitzgerald rating of Complete Solaria (NASDAQ:CSLR) on 11/14/2024 |
RKLB Rocket Lab USA | $23.26
+3.8% | 11/14/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $24.00 | N/A | View details for Cantor Fitzgerald rating of Rocket Lab USA (NASDAQ:RKLB) on 11/14/2024 |
CYBR CyberArk Software | $319.73
-2.9% | 11/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $335.00 -> $335.00 | N/A | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 11/14/2024 |
MRNS Marinus Pharmaceuticals | $0.33
| 11/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 -> $4.00 | N/A | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 11/14/2024 |
ALMS Alumis | $9.46
+0.2% | 11/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | N/A | View details for Cantor Fitzgerald rating of Alumis (NASDAQ:ALMS) on 11/14/2024 |
CAPR Capricor Therapeutics | $18.62
+4.7% | 11/14/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 -> $30.00 | N/A | View details for Cantor Fitzgerald rating of Capricor Therapeutics (NASDAQ:CAPR) on 11/14/2024 |
INVZ Innoviz Technologies | $0.53
| 11/14/2024 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | | N/A | View details for Cantor Fitzgerald rating of Innoviz Technologies (NASDAQ:INVZ) on 11/14/2024 |
GTLB GitLab | $66.62
+2.8% | 11/12/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 11/12/2024 |
TSHA Taysha Gene Therapies | $2.47
+13.3% | 11/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $7.00 | N/A | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 11/12/2024 |
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
ALXO ALX Oncology | $1.41
+9.3% | 11/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 11/12/2024 |
OUST Ouster | $9.54
+6.2% | 11/11/2024 | Upgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Overweight | $12.00 -> $10.00 | N/A | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 11/11/2024 |
CDE Coeur Mining | $6.57
-0.9% | 11/7/2024 | Upgraded by | Cantor Fitzgerald | Analyst M. Kozak | Hold -> Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Coeur Mining (NYSE:CDE) on 11/7/2024 |
NRDY Nerdy | $1.41
+6.0% | 11/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Neutral | $6.00 -> $1.00 | N/A | View details for Cantor Fitzgerald rating of Nerdy (NYSE:NRDY) on 11/8/2024 |
FOLD Amicus Therapeutics | $9.66
+1.7% | 11/7/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 -> $21.00 | N/A | View details for Cantor Fitzgerald rating of Amicus Therapeutics (NASDAQ:FOLD) on 11/7/2024 |
LYFT Lyft | $16.79
+3.1% | 11/7/2024 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $13.00 -> $16.00 | N/A | View details for Cantor Fitzgerald rating of Lyft (NASDAQ:LYFT) on 11/7/2024 |
MELI MercadoLibre | $2,005.00
+1.9% | 11/7/2024 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $2,530.00 -> $2,300.00 | N/A | View details for Cantor Fitzgerald rating of MercadoLibre (NASDAQ:MELI) on 11/7/2024 |
TRIP Tripadvisor | $13.87
+3.1% | 11/7/2024 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Underweight -> Underweight | $12.00 -> $11.00 | N/A | View details for Cantor Fitzgerald rating of Tripadvisor (NASDAQ:TRIP) on 11/7/2024 |
QCOM QUALCOMM | $156.79
+0.9% | 11/7/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $160.00 -> $160.00 | N/A | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 11/7/2024 |
KVYO Klaviyo | $36.87
+0.7% | 11/7/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $33.00 -> $47.00 | N/A | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 11/7/2024 |
JANX Janux Therapeutics | $50.31
+8.2% | 11/7/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $100.00 -> $100.00 | N/A | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 11/7/2024 |
GILD Gilead Sciences | $90.19
+0.5% | 11/7/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $70.00 -> $80.00 | N/A | View details for Cantor Fitzgerald rating of Gilead Sciences (NASDAQ:GILD) on 11/7/2024 |
SRPT Sarepta Therapeutics | $114.23
+3.4% | 11/7/2024 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Neutral -> Overweight | $152.00 -> $167.00 | N/A | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/7/2024 |
QURE uniQure | $5.78
-1.0% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 -> $28.00 | N/A | View details for Cantor Fitzgerald rating of uniQure (NASDAQ:QURE) on 11/6/2024 |
PCVX Vaxcyte | $88.54
+0.2% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Vaxcyte (NASDAQ:PCVX) on 11/6/2024 |
BBAI BigBear.ai | $2.45
+11.4% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | $3.50 | N/A | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 11/6/2024 |
NVO Novo Nordisk A/S | $105.07
+2.4% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $160.00 -> $160.00 | N/A | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 11/6/2024 |
GFS GlobalFoundries | $42.80
+1.9% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $40.00 -> $40.00 | N/A | View details for Cantor Fitzgerald rating of GlobalFoundries (NASDAQ:GFS) on 11/6/2024 |
KURA Kura Oncology | $10.80
+7.4% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Kura Oncology (NASDAQ:KURA) on 11/6/2024 |
XMTR Xometry | $31.40
+1.1% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Underweight -> Underweight | $12.00 | N/A | View details for Cantor Fitzgerald rating of Xometry (NASDAQ:XMTR) on 11/6/2024 |
RARE Ultragenyx Pharmaceutical | $47.24
+2.7% | 11/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $116.00 -> $116.00 | N/A | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 11/6/2024 |
EVEX EVE | $3.35
+1.8% | 11/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $5.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of EVE (NYSE:EVEX) on 11/5/2024 |
VRTX Vertex Pharmaceuticals | $450.97
+0.1% | 11/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $480.00 -> $480.00 | Medium | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 11/5/2024 |
ASND Ascendis Pharma A/S | $129.81
+5.8% | 11/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $170.00 -> $170.00 | High | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/4/2024 |
NXPI NXP Semiconductors | $226.38
+0.8% | 11/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $270.00 -> $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 11/4/2024 |
PRLB Proto Labs | $41.50
+4.4% | 11/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $40.00 -> $40.00 | High | View details for Cantor Fitzgerald rating of Proto Labs (NYSE:PRLB) on 11/4/2024 |
PANW Palo Alto Networks | $383.36
-3.6% | 11/1/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 11/1/2024 |
PANW Palo Alto Networks | $383.36
-3.6% | 10/31/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $400.00 -> $415.00 | Low | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 10/31/2024 |
AMD Advanced Micro Devices | $138.35
+0.6% | 10/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 -> $180.00 | Medium | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 10/30/2024 |
BMRN BioMarin Pharmaceutical | $64.26
+1.3% | 10/30/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $110.00 -> $90.00 | High | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 10/30/2024 |
SNAP Snap | $11.42
+7.3% | 10/30/2024 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $8.00 -> $9.00 | Low | View details for Cantor Fitzgerald rating of Snap (NYSE:SNAP) on 10/30/2024 |
GOOGL Alphabet | $164.76
-1.7% | 10/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $190.00 -> $190.00 | High | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 10/30/2024 |
IREN Iris Energy | $10.78
+10.9% | 10/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $20.00 -> $20.00 | Medium | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 10/30/2024 |
HRMY Harmony Biosciences | $34.07
+2.5% | 10/30/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $51.00 -> $58.00 | High | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 10/30/2024 |
THC Tenet Healthcare | $143.57
-2.9% | 10/30/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $168.00 -> $177.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 10/30/2024 |
ENVX Enovix | $9.43
+3.6% | 10/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 10/30/2024 |
UDMY Udemy | $7.68
+1.7% | 10/30/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $18.00 -> $11.00 | High | View details for Cantor Fitzgerald rating of Udemy (NASDAQ:UDMY) on 10/30/2024 |
ABEO Abeona Therapeutics | $5.98
+3.3% | 10/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $18.00 -> $18.00 | High | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 10/29/2024 |
FROG JFrog | $32.15
+0.7% | 10/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight | $35.00 | Low | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 10/29/2024 |
FTNT Fortinet | $92.77
-1.3% | 10/29/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 -> $88.00 | Medium | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 10/29/2024 |
CYBR CyberArk Software | $319.73
-2.9% | 10/29/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $300.00 -> $335.00 | High | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 10/29/2024 |
HIVE HIVE Digital Technologies | $4.09
+2.3% | 10/29/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | $9.00 | Low | View details for Cantor Fitzgerald rating of HIVE Digital Technologies (NASDAQ:HIVE) on 10/29/2024 |
ZLAB Zai Lab | $26.43
+2.8% | 10/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 10/25/2024 |
WDC Western Digital | $66.43
+0.8% | 10/25/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $80.00 -> $95.00 | High | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 10/25/2024 |
COUR Coursera | $7.11
+1.9% | 10/25/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $22.00 -> $10.00 | Medium | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 10/25/2024 |
ALKS Alkermes | $28.78
+3.9% | 10/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 -> $43.00 | Medium | View details for Cantor Fitzgerald rating of Alkermes (NASDAQ:ALKS) on 10/25/2024 |
UHS Universal Health Services | $197.94
+0.2% | 10/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Neutral -> Neutral | $219.00 -> $219.00 | Medium | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 10/25/2024 |
MRNS Marinus Pharmaceuticals | $0.33
| 10/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $4.00 | High | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 10/25/2024 |
LRCX Lam Research | $72.64
-0.7% | 10/24/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $100.00 -> $100.00 | Medium | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 10/24/2024 |
PI Impinj | $191.04
+1.5% | 10/24/2024 | Target Raised by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $205.00 -> $260.00 | High | View details for Cantor Fitzgerald rating of Impinj (NASDAQ:PI) on 10/24/2024 |
2024 Election Year Stocks: Uncover Hidden Gems! (Ad) In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss. Secure your copy now by clicking this link. |
MOH Molina Healthcare | $290.79
-1.8% | 10/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $406.00 -> $406.00 | High | View details for Cantor Fitzgerald rating of Molina Healthcare (NYSE:MOH) on 10/24/2024 |
KROS Keros Therapeutics | $55.92
+3.9% | 10/24/2024 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | High | View details for Cantor Fitzgerald rating of Keros Therapeutics (NASDAQ:KROS) on 10/24/2024 |
CI The Cigna Group | $328.43
-0.5% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $400.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 10/23/2024 |
TXN Texas Instruments | $198.00
-0.1% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $200.00 -> $200.00 | Medium | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 10/23/2024 |
TSLA Tesla | $352.56
+3.8% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $245.00 -> $245.00 | Low | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 10/23/2024 |
BHVN Biohaven | $45.59
+0.9% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Medium | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 10/23/2024 |
CVRX CVRx | $14.85
+0.5% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $14.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of CVRx (NASDAQ:CVRX) on 10/23/2024 |
STX Seagate Technology | $99.62
-0.3% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $125.00 -> $125.00 | Medium | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 10/23/2024 |
REGN Regeneron Pharmaceuticals | $738.00
-0.9% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $1,015.00 -> $1,015.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 10/23/2024 |
PFE Pfizer | $25.63
+2.0% | 10/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 10/23/2024 |
AMGN Amgen | $294.53
+1.6% | 10/22/2024 | Reiterated by | Cantor Fitzgerald | Analyst O. Brayer | Overweight -> Overweight | $405.00 -> $405.00 | High | View details for Cantor Fitzgerald rating of Amgen (NASDAQ:AMGN) on 10/22/2024 |
RARE Ultragenyx Pharmaceutical | $47.24
+2.7% | 10/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $116.00 -> $116.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 10/22/2024 |
BMY Bristol-Myers Squibb | $58.87
+1.1% | 10/18/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $50.00 -> $50.00 | Low | View details for Cantor Fitzgerald rating of Bristol-Myers Squibb (NYSE:BMY) on 10/18/2024 |
VSTM Verastem | $4.00
+1.8% | 10/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | High | View details for Cantor Fitzgerald rating of Verastem (NASDAQ:VSTM) on 10/18/2024 |
CYTK Cytokinetics | $49.10
+3.0% | 10/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | High | View details for Cantor Fitzgerald rating of Cytokinetics (NASDAQ:CYTK) on 10/18/2024 |
ELV Elevance Health | $402.55
-0.3% | 10/18/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $600.00 -> $485.00 | Medium | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 10/18/2024 |
ZURA Zura Bio | $2.73
-6.8% | 10/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | | Low | View details for Cantor Fitzgerald rating of Zura Bio (NASDAQ:ZURA) on 10/18/2024 |
PCT PureCycle Technologies | $11.93
+2.1% | 10/18/2024 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | $14.00 | High | View details for Cantor Fitzgerald rating of PureCycle Technologies (NASDAQ:PCT) on 10/18/2024 |
LILM Lilium | $0.05
-37.0% | 10/18/2024 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | $2.00 -> $1.00 | High | View details for Cantor Fitzgerald rating of Lilium (NASDAQ:LILM) on 10/18/2024 |
UNH UnitedHealth Group | $590.77
-1.1% | 10/16/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 -> $644.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 10/16/2024 |
JNJ Johnson & Johnson | $155.14
-0.2% | 10/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $215.00 -> $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 10/16/2024 |
META Meta Platforms | $559.14
-0.7% | 10/16/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $670.00 -> $670.00 | Low | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 10/16/2024 |
TRML Tourmaline Bio | $23.01
+1.3% | 10/15/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Schimmer | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Tourmaline Bio (NASDAQ:TRML) on 10/15/2024 |
IRON Disc Medicine | $64.96
+2.3% | 10/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $85.00 -> $85.00 | Low | View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 10/15/2024 |
IDYA IDEAYA Biosciences | $26.79
+0.7% | 10/15/2024 | Initiated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight | | Medium | View details for Cantor Fitzgerald rating of IDEAYA Biosciences (NASDAQ:IDYA) on 10/15/2024 |
LMAT LeMaitre Vascular | $107.97
+2.0% | 10/15/2024 | Initiated by | Cantor Fitzgerald | Analyst R. Osborn | Neutral | $96.00 | Medium | View details for Cantor Fitzgerald rating of LeMaitre Vascular (NASDAQ:LMAT) on 10/15/2024 |
LBPH Longboard Pharmaceuticals | $59.80
+0.1% | 10/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Neutral | | High | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 10/14/2024 |
ZVRA Zevra Therapeutics | $9.59
+5.0% | 10/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 10/11/2024 |
MDGL Madrigal Pharmaceuticals | $347.45
+5.5% | 10/11/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Neutral | | Low | View details for Cantor Fitzgerald rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 10/11/2024 |
SYM Symbotic | $38.79
+6.9% | 10/11/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 -> $60.00 | Medium | View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 10/11/2024 |
ALNY Alnylam Pharmaceuticals | $244.89
-0.8% | 10/11/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $220.00 -> $220.00 | Low | View details for Cantor Fitzgerald rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 10/11/2024 |
JNJ Johnson & Johnson | $155.14
-0.2% | 10/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $215.00 -> $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 10/10/2024 |
ALKS Alkermes | $28.78
+3.9% | 10/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 -> $48.00 | High | View details for Cantor Fitzgerald rating of Alkermes (NASDAQ:ALKS) on 10/10/2024 |
NVO Novo Nordisk A/S | $105.07
+2.4% | 10/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $160.00 -> $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 10/10/2024 |
MARA MARA | $26.03
+7.7% | 10/10/2024 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | $21.00 | Low | View details for Cantor Fitzgerald rating of MARA (NASDAQ:MARA) on 10/10/2024 |
AVGO Broadcom | $164.23
+0.2% | 10/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $200.00 -> $225.00 | Low | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 10/8/2024 |
GFS GlobalFoundries | $42.80
+1.9% | 10/8/2024 | Target Lowered by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $55.00 -> $40.00 | Low | View details for Cantor Fitzgerald rating of GlobalFoundries (NASDAQ:GFS) on 10/8/2024 |
NXPI NXP Semiconductors | $226.38
+0.8% | 10/8/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $350.00 -> $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 10/8/2024 |
QCOM QUALCOMM | $156.79
+0.9% | 10/8/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $215.00 -> $160.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 10/8/2024 |
TXN Texas Instruments | $198.00
-0.1% | 10/8/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $210.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 10/8/2024 |
ADI Analog Devices | $214.59
+0.3% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $250.00 -> $250.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 10/8/2024 |
AMAT Applied Materials | $174.88
-0.5% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $250.00 -> $250.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 10/8/2024 |
KLAC KLA | $639.55
+1.0% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $925.00 -> $925.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 10/8/2024 |
NVDA NVIDIA | $141.95
-3.2% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $175.00 -> $175.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 10/8/2024 |
LCID Lucid Group | $2.10
+1.9% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $4.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 10/8/2024 |
SPRY ARS Pharmaceuticals | $14.00
+4.6% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $30.00 -> $30.00 | Low | View details for Cantor Fitzgerald rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 10/8/2024 |
VRTX Vertex Pharmaceuticals | $450.97
+0.1% | 10/8/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $480.00 -> $480.00 | Medium | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 10/8/2024 |
BCAX Bicara Therapeutics | $18.09
+1.8% | 10/8/2024 | Initiated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | High | View details for Cantor Fitzgerald rating of Bicara Therapeutics (NASDAQ:BCAX) on 10/8/2024 |
ACHR Archer Aviation | $6.04
+4.3% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | High | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 10/7/2024 |
UBER Uber Technologies | $71.49
+2.7% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $90.00 -> $90.00 | Low | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 10/7/2024 |
When it comes to NVDA… “acceleration cycles” are the key (Ad) Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options…
By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)...
And thanks to many months and late nights working out the kinks of the systems…
They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! |
WIX Wix.com | $217.20
-0.9% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $200.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of Wix.com (NASDAQ:WIX) on 10/7/2024 |
ZG Zillow Group | $80.79
+1.9% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $47.00 -> $47.00 | Low | View details for Cantor Fitzgerald rating of Zillow Group (NASDAQ:ZG) on 10/7/2024 |
SPOT Spotify Technology | $475.04
+0.9% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $340.00 -> $340.00 | Medium | View details for Cantor Fitzgerald rating of Spotify Technology (NYSE:SPOT) on 10/7/2024 |
TRIP Tripadvisor | $13.87
+3.1% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Underweight -> Underweight | $12.00 -> $12.00 | Low | View details for Cantor Fitzgerald rating of Tripadvisor (NASDAQ:TRIP) on 10/7/2024 |
TTD Trade Desk | $129.70
+1.8% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $110.00 -> $110.00 | Low | View details for Cantor Fitzgerald rating of Trade Desk (NASDAQ:TTD) on 10/7/2024 |
PINS Pinterest | $30.01
+2.4% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $41.00 -> $41.00 | Low | View details for Cantor Fitzgerald rating of Pinterest (NYSE:PINS) on 10/7/2024 |
SHOP Shopify | $106.96
+0.5% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $70.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of Shopify (NYSE:SHOP) on 10/7/2024 |
SNAP Snap | $11.42
+7.3% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $8.00 -> $8.00 | Medium | View details for Cantor Fitzgerald rating of Snap (NYSE:SNAP) on 10/7/2024 |
AMD Advanced Micro Devices | $138.35
+0.6% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 -> $180.00 | Medium | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 10/7/2024 |
TSLA Tesla | $352.56
+3.8% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $245.00 -> $245.00 | Low | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 10/7/2024 |
ABNB Airbnb | $137.34
+3.1% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Underweight -> Underweight | $94.00 -> $94.00 | Low | View details for Cantor Fitzgerald rating of Airbnb (NASDAQ:ABNB) on 10/7/2024 |
AMZN Amazon.com | $197.12
-0.6% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $230.00 -> $230.00 | Low | View details for Cantor Fitzgerald rating of Amazon.com (NASDAQ:AMZN) on 10/7/2024 |
BKNG Booking | $5,177.15
-0.6% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $3,590.00 -> $3,590.00 | High | View details for Cantor Fitzgerald rating of Booking (NASDAQ:BKNG) on 10/7/2024 |
CART Maplebear | $43.22
-0.1% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $45.00 -> $45.00 | Medium | View details for Cantor Fitzgerald rating of Maplebear (NASDAQ:CART) on 10/7/2024 |
DASH DoorDash | $177.24
+2.4% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $160.00 -> $160.00 | Low | View details for Cantor Fitzgerald rating of DoorDash (NASDAQ:DASH) on 10/7/2024 |
EBAY eBay | $63.24
+3.0% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $62.00 -> $62.00 | Low | View details for Cantor Fitzgerald rating of eBay (NASDAQ:EBAY) on 10/7/2024 |
ETSY Etsy | $52.30
+0.6% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $50.00 -> $50.00 | Medium | View details for Cantor Fitzgerald rating of Etsy (NASDAQ:ETSY) on 10/7/2024 |
EXPE Expedia Group | $184.92
+0.8% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $130.00 -> $130.00 | Low | View details for Cantor Fitzgerald rating of Expedia Group (NASDAQ:EXPE) on 10/7/2024 |
GDDY GoDaddy | $196.41
+1.8% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $170.00 -> $170.00 | Medium | View details for Cantor Fitzgerald rating of GoDaddy (NYSE:GDDY) on 10/7/2024 |
GOOGL Alphabet | $164.76
-1.7% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $190.00 -> $190.00 | High | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 10/7/2024 |
LYFT Lyft | $16.79
+3.1% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $13.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Lyft (NASDAQ:LYFT) on 10/7/2024 |
MELI MercadoLibre | $2,005.00
+1.9% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $2,530.00 -> $2,530.00 | Low | View details for Cantor Fitzgerald rating of MercadoLibre (NASDAQ:MELI) on 10/7/2024 |
META Meta Platforms | $559.14
-0.7% | 10/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $660.00 -> $660.00 | N/A | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 10/7/2024 |
DNLI Denali Therapeutics | $24.69
+1.9% | 10/7/2024 | Downgraded by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Neutral | | High | View details for Cantor Fitzgerald rating of Denali Therapeutics (NASDAQ:DNLI) on 10/7/2024 |
SGRY Surgery Partners | $23.01
-1.5% | 10/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 -> $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 10/4/2024 |
TBRG TruBridge | $16.54
+3.3% | 10/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 10/4/2024 |
BHVN Biohaven | $45.59
+0.9% | 10/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 10/4/2024 |
HCAT Health Catalyst | $8.13
+6.1% | 10/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 -> $16.00 | Medium | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 10/4/2024 |
RCM R1 RCM | $14.31
| 10/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Neutral -> Neutral | $14.30 -> $14.30 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 10/4/2024 |
PAY Payfare | C$2.01
-0.5% | 10/3/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Payfare (TSE:PAY) on 10/3/2024 |
STNE StoneCo | $10.26
+10.7% | 10/3/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of StoneCo (NASDAQ:STNE) on 10/3/2024 |
ROOT Root | $109.23
-0.2% | 10/3/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Root (NASDAQ:ROOT) on 10/3/2024 |
PAGS PagSeguro Digital | $7.94
+5.7% | 10/3/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of PagSeguro Digital (NYSE:PAGS) on 10/3/2024 |
ML MoneyLion | $87.00
+8.4% | 10/3/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Strong-Buy | | High | View details for Cantor Fitzgerald rating of MoneyLion (NYSE:ML) on 10/3/2024 |
KPLT Katapult | $6.61
+5.6% | 10/3/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Hold | | Medium | View details for Cantor Fitzgerald rating of Katapult (NASDAQ:KPLT) on 10/3/2024 |
BITF Bitfarms | $2.11
+2.9% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $5.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 10/3/2024 |
BTDR Bitdeer Technologies Group | $11.54
+3.1% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $13.00 -> $13.00 | Medium | View details for Cantor Fitzgerald rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 10/3/2024 |
CIFR Cipher Mining | $6.78
+9.5% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $9.00 -> $9.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 10/3/2024 |
CLSK CleanSpark | $15.10
+16.4% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $23.00 -> $23.00 | Low | View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 10/3/2024 |
CORZ Core Scientific | $18.23
+3.9% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $20.00 -> $20.00 | Low | View details for Cantor Fitzgerald rating of Core Scientific (NASDAQ:CORZ) on 10/3/2024 |
IREN Iris Energy | $10.78
+10.9% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $20.00 -> $20.00 | Medium | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 10/3/2024 |
RIOT Riot Platforms | $12.31
+4.7% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $22.00 -> $22.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 10/3/2024 |
WULF TeraWulf | $7.45
+6.6% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $10.00 -> $10.00 | High | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 10/3/2024 |
MRK Merck & Co., Inc. | $99.17
-0.7% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $155.00 -> $155.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 10/3/2024 |
PFE Pfizer | $25.63
+2.0% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 10/3/2024 |
RCUS Arcus Biosciences | $14.70
+2.9% | 10/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Medium | View details for Cantor Fitzgerald rating of Arcus Biosciences (NYSE:RCUS) on 10/3/2024 |
LASR nLIGHT | $11.39
+2.5% | 10/3/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Siegler | Overweight | $15.50 | Medium | View details for Cantor Fitzgerald rating of nLIGHT (NASDAQ:LASR) on 10/3/2024 |
UHS Universal Health Services | $197.94
+0.2% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Neutral -> Neutral | $219.00 -> $219.00 | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 10/1/2024 |
UNH UnitedHealth Group | $590.77
-1.1% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 -> $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 10/1/2024 |
PGNY Progyny | $15.44
+3.1% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 -> $25.00 | Low | View details for Cantor Fitzgerald rating of Progyny (NASDAQ:PGNY) on 10/1/2024 |
When it comes to NVDA… “acceleration cycles” are the key (Ad) Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options…
By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)...
And thanks to many months and late nights working out the kinks of the systems…
They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! |
THC Tenet Healthcare | $143.57
-2.9% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $168.00 -> $168.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 10/1/2024 |
ACHC Acadia Healthcare | $38.23
-0.9% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $90.00 -> $90.00 | Low | View details for Cantor Fitzgerald rating of Acadia Healthcare (NASDAQ:ACHC) on 10/1/2024 |
CI The Cigna Group | $328.43
-0.5% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $400.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 10/1/2024 |
CNC Centene | $60.37
+0.0% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 -> $90.00 | Medium | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 10/1/2024 |
CVS CVS Health | $58.01
+1.6% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Neutral -> Neutral | $62.00 -> $62.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 10/1/2024 |
ELV Elevance Health | $402.55
-0.3% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $600.00 -> $600.00 | Medium | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 10/1/2024 |
HCA HCA Healthcare | $324.92
-2.2% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $392.00 -> $392.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 10/1/2024 |
HUM Humana | $298.11
+0.8% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $395.00 -> $395.00 | High | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 10/1/2024 |
MOH Molina Healthcare | $290.79
-1.8% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $406.00 -> $406.00 | Low | View details for Cantor Fitzgerald rating of Molina Healthcare (NYSE:MOH) on 10/1/2024 |
RARE Ultragenyx Pharmaceutical | $47.24
+2.7% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $116.00 -> $116.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 10/1/2024 |
VERA Vera Therapeutics | $48.31
+2.7% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 -> $107.00 | High | View details for Cantor Fitzgerald rating of Vera Therapeutics (NASDAQ:VERA) on 10/1/2024 |
CSLR Complete Solaria | $1.94
| 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $6.00 | High | View details for Cantor Fitzgerald rating of Complete Solaria (NASDAQ:CSLR) on 10/1/2024 |
MU Micron Technology | $102.64
-0.1% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $150.00 -> $150.00 | Medium | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 10/1/2024 |
ZVRA Zevra Therapeutics | $9.59
+5.0% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Medium | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 10/1/2024 |
MREO Mereo BioPharma Group | $3.72
+1.1% | 10/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $7.00 | Medium | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 10/1/2024 |
META Meta Platforms | $559.14
-0.7% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $660.00 -> $660.00 | Low | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 9/30/2024 |
PINS Pinterest | $30.01
+2.4% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $41.00 -> $41.00 | Low | View details for Cantor Fitzgerald rating of Pinterest (NYSE:PINS) on 9/30/2024 |
SHOP Shopify | $106.96
+0.5% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $70.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of Shopify (NYSE:SHOP) on 9/30/2024 |
SNAP Snap | $11.42
+7.3% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $8.00 -> $8.00 | Medium | View details for Cantor Fitzgerald rating of Snap (NYSE:SNAP) on 9/30/2024 |
SPOT Spotify Technology | $475.04
+0.9% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $340.00 -> $340.00 | Low | View details for Cantor Fitzgerald rating of Spotify Technology (NYSE:SPOT) on 9/30/2024 |
TRIP Tripadvisor | $13.87
+3.1% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Underweight -> Underweight | $12.00 -> $12.00 | Low | View details for Cantor Fitzgerald rating of Tripadvisor (NASDAQ:TRIP) on 9/30/2024 |
TTD Trade Desk | $129.70
+1.8% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $110.00 -> $110.00 | Low | View details for Cantor Fitzgerald rating of Trade Desk (NASDAQ:TTD) on 9/30/2024 |
UBER Uber Technologies | $71.49
+2.7% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $90.00 -> $90.00 | Low | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 9/30/2024 |
WIX Wix.com | $217.20
-0.9% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $200.00 -> $200.00 | Medium | View details for Cantor Fitzgerald rating of Wix.com (NASDAQ:WIX) on 9/30/2024 |
ZG Zillow Group | $80.79
+1.9% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $47.00 -> $47.00 | Low | View details for Cantor Fitzgerald rating of Zillow Group (NASDAQ:ZG) on 9/30/2024 |
ABNB Airbnb | $137.34
+3.1% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Underweight -> Underweight | $94.00 -> $94.00 | Low | View details for Cantor Fitzgerald rating of Airbnb (NASDAQ:ABNB) on 9/30/2024 |
AMZN Amazon.com | $197.12
-0.6% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $230.00 -> $230.00 | Low | View details for Cantor Fitzgerald rating of Amazon.com (NASDAQ:AMZN) on 9/30/2024 |
BKNG Booking | $5,177.15
-0.6% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $3,590.00 -> $3,590.00 | Low | View details for Cantor Fitzgerald rating of Booking (NASDAQ:BKNG) on 9/30/2024 |
CART Maplebear | $43.22
-0.1% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $45.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of Maplebear (NASDAQ:CART) on 9/30/2024 |
DASH DoorDash | $177.24
+2.4% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $160.00 -> $160.00 | Low | View details for Cantor Fitzgerald rating of DoorDash (NASDAQ:DASH) on 9/30/2024 |
EBAY eBay | $63.24
+3.0% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $62.00 -> $62.00 | Low | View details for Cantor Fitzgerald rating of eBay (NASDAQ:EBAY) on 9/30/2024 |
ETSY Etsy | $52.30
+0.6% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $50.00 -> $50.00 | Low | View details for Cantor Fitzgerald rating of Etsy (NASDAQ:ETSY) on 9/30/2024 |
EXPE Expedia Group | $184.92
+0.8% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $130.00 -> $130.00 | Low | View details for Cantor Fitzgerald rating of Expedia Group (NASDAQ:EXPE) on 9/30/2024 |
GDDY GoDaddy | $196.41
+1.8% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $170.00 -> $170.00 | Low | View details for Cantor Fitzgerald rating of GoDaddy (NYSE:GDDY) on 9/30/2024 |
GOOGL Alphabet | $164.76
-1.7% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $190.00 -> $190.00 | Low | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 9/30/2024 |
LYFT Lyft | $16.79
+3.1% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $13.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Lyft (NASDAQ:LYFT) on 9/30/2024 |
OUST Ouster | $9.54
+6.2% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $12.00 -> $12.00 | Medium | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 9/30/2024 |
PSNY Polestar Automotive Holding UK | $1.14
+3.6% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Polestar Automotive Holding UK (NASDAQ:PSNY) on 9/30/2024 |
RDW Redwire | $13.17
+12.8% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $6.00 | High | View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 9/30/2024 |
RIVN Rivian Automotive | $10.24
+2.2% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 -> $19.00 | Low | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 9/30/2024 |
RKLB Rocket Lab USA | $23.26
+3.8% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $7.00 | Medium | View details for Cantor Fitzgerald rating of Rocket Lab USA (NASDAQ:RKLB) on 9/30/2024 |
TSLA Tesla | $352.56
+3.8% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $245.00 -> $245.00 | Medium | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 9/30/2024 |
VFS VinFast Auto | $3.93
-0.5% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $6.00 | Low | View details for Cantor Fitzgerald rating of VinFast Auto (NASDAQ:VFS) on 9/30/2024 |
ACHR Archer Aviation | $6.04
+4.3% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | Medium | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 9/30/2024 |
EVEX EVE | $3.35
+1.8% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $5.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of EVE (NYSE:EVEX) on 9/30/2024 |
EVGO EVgo | $6.36
+1.8% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $5.00 -> $5.00 | Medium | View details for Cantor Fitzgerald rating of EVgo (NYSE:EVGO) on 9/30/2024 |
INVZ Innoviz Technologies | $0.53
| 9/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.00 -> $2.00 | Low | View details for Cantor Fitzgerald rating of Innoviz Technologies (NASDAQ:INVZ) on 9/30/2024 |
JOBY Joby Aviation | $7.09
+4.3% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | High | View details for Cantor Fitzgerald rating of Joby Aviation (NYSE:JOBY) on 9/30/2024 |
LCID Lucid Group | $2.10
+1.9% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $4.00 -> $4.00 | Medium | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 9/30/2024 |
LILM Lilium | $0.05
-37.0% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $2.00 -> $2.00 | Low | View details for Cantor Fitzgerald rating of Lilium (NASDAQ:LILM) on 9/30/2024 |
LUNR Intuitive Machines | $15.12
+8.0% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | High | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 9/30/2024 |
LRCX Lam Research | $72.64
-0.7% | 9/30/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $120.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 9/30/2024 |
JNJ Johnson & Johnson | $155.14
-0.2% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $215.00 -> $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 9/30/2024 |
PRTA Prothena | $14.60
+1.1% | 9/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | High | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 9/30/2024 |
KLAC KLA | $639.55
+1.0% | 9/30/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $950.00 -> $925.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 9/30/2024 |
AMGN Amgen | $294.53
+1.6% | 9/27/2024 | Initiated by | Cantor Fitzgerald | Analyst O. Brayer | Overweight | $405.00 | Low | View details for Cantor Fitzgerald rating of Amgen (NASDAQ:AMGN) on 9/27/2024 |
MKFG Markforged | $4.39
-0.5% | 9/26/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Neutral | $8.50 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Markforged (NYSE:MKFG) on 9/26/2024 |
BHVN Biohaven | $45.59
+0.9% | 9/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Medium | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 9/24/2024 |
MRNS Marinus Pharmaceuticals | $0.33
| 9/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $13.00 | High | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 9/24/2024 |
NNOX Nano-X Imaging | $6.36
+3.2% | 9/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 9/23/2024 |
